'World-first' vaccine designed by Artificial Intelligence
Summary
Researchers at the University of Cambridge used artificial intelligence (AI) to design a new kind of vaccine that could protect against many types of coronaviruses, including future versions and related animal viruses. Early human trials showed it is safe, and the team is now working on similar AI-designed vaccines for flu and Ebola.Key Facts
- This is the first time AI fully designed a vaccine component called an antigen, which trains the immune system.
- The vaccine aims to protect against all coronaviruses, not just current variants like COVID-19.
- The team used genetic information from many known coronaviruses to create a "super-antigen" with AI.
- Trials with 39 people tested the vaccine’s safety, and a larger trial with about 200 participants is ongoing.
- The vaccine’s effect on the immune system was modest but promising, according to researchers.
- Researchers are also developing AI-designed vaccines for flu, bird flu (H5N1), and viral diseases like Ebola.
- Experts not involved in the study say this AI vaccine design shows strong potential for fighting future pandemics.
- The approach represents a new way to prepare for outbreaks by creating vaccines that work before viruses mutate.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.